Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-23Clinical Trial Update: Parental Attitudes and Beliefs Regarding Risks Associated With Opioid Use in Children With Cancer
An ongoing MD Anderson Cancer Center study investigates parental attitudes toward opioid risks in pediatric cancer patients; the trial is cu…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors [Phase 2]
Phase 2 clinical trial evaluating trastuzumab deruxtecan (T-DXd) as monotherapy or in combination with anti-cancer agents for selected HER2-…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies [Phase 1]
Open-label Phase 1 safety and tolerability study of INCB062079 in patients with advanced hepatocellular carcinoma and other malignancies; st…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes [Phase 1]
Phase 1 pharmacokinetic study update characterizes belinostat exposure across patients with different UGT1A1*28 genotypes (wild-type, hetero…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors [Phase 1]
This first-in-human Phase 1 study of BAY2862789 aims to assess safety, determine the recommended dose, characterize pharmacokinetics/pharmac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial assesses ABBV-706 alone or in combination with budigalimab, cisplatin, or carboplatin in adults with advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors [Phase 1]
Phase Ib study evaluating a combination of metformin, digoxin, and simvastatin in advanced pancreatic cancer and other solid tumors.
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
St. Jude Children's Research Hospital is conducting a prospective study to perform next-generation sequencing on normal tissues in pediatric…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children [Phase 1]
Phase 1 pediatric trial update evaluating carfilzomib with cyclophosphamide and etoposide for relapsed or refractory solid tumors and leukem…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1a/1b study of ACTM-838 in patients with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Imaging of Solid Tumors Using DLL3 SPECT [EARLY_Phase 1]
Early Phase 1 clinical trial evaluating DLL3 SPECT imaging for solid tumors, including castration-resistant prostate cancer and neuroendocri…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001) [Phase 1]
This Phase 1 trial update reports on MK-4464 as a monotherapy and in combination with pembrolizumab for participants with advanced or metast…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Futibatinib in Patients With Specific FGFR Aberrations [Phase 2]
Taiho Oncology reports a Phase 2 trial of futibatinib in patients with FGFR aberrations across advanced cancers. The study (NCT04189445) was…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial [NA]
A completed pragmatic clinical trial at Mayo Clinic evaluating enhanced, electronic health record–facilitated cancer symptom control; result…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 ADME trial assessing absorption, distribution, metabolism, and excretion of radiolabeled Subasumstat in adults with advanced or meta…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors [Phase 1]
Phase 1 trial update for a personalized KXV01 TCR Lentinvivo Injection intended to treat advanced solid tumors; the study is not yet recruit…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials [NA]
Clinical trial update from Institut Bergonié describes profiling patients with cancer to match molecular alterations with experimental drugs…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Study of TTX-MC138 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
This document provides a clinical trial update for TTX-MC138 in adults with advanced solid tumors, covering Phase 1 and Phase 2 studies that…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases [Phase 1]
This update describes the first-in-human Phase 1 trial of AO-252, an oral TACC3 protein-protein interaction inhibitor, in patients with adva…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Evaluation of Safety and Tolerability of ATB-320 in Participants With Progressive or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating the safety and tolerability of ATB-320 in participants with progressive or metastatic solid tumors. The st…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy [Phase 4]
Phase 4 rollover study of sacituzumab govitecan-hziy in participants with metastatic solid tumors; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors [Phase 1]
This document reports an ongoing Phase 1 study of ZV0203 for patients with HER2-positive advanced solid tumors, currently enrolling by invit…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their Caregivers [NA]
Clinical trial assessing a positive activities intervention to improve quality of life for cancer patients and their caregivers in collectiv…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update for GNC-039, a tetra-specific antibody, in relapsed/refractory or metastatic solid tumors; currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for KXV01 TCR Lentinvivo injection in advanced solid tumors; the study is not yet recruiting.